Nanjing Leads Biolabs Co. Ltd. is a biopharmaceutical company focusing on R&D of innovative cancer immune-therapeutic antibody drugs.
Suzhou Connect biopharma is a clinical-stage company that discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation.
CureGenix is a clinical stage Wnt pathway targeted therapeutics development company.
Sensulin is developing a true once-a-day glucose responsive insulin that may mimic a healthy human pancreas.
Aucta is a pharmaceutical company developing novel sustained-release formulations of drugs.
CF PharmTech is a pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market.
PegBio is a leading biopharmaceutical company in China focused on the development and commercialization of innovative drugs for diabetes and obesity.
NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs.
MabVenture is a leading CRO/CMO platfrom for biological drug development.
AMT Medical employs a novel 3-D printing platform to develop bioresorbable stents.
Gateway Medical is a large animal study CRO for medical devices.
Gemstone Biotherapeutics is a Baltimore-based research and development company focused on developing innovative, high efficacy, evidence-based advanced wound care solutions.
SINO PRECISION is the leading company of neurosurgery robot and surgical navigation system in China.
Neuracle is a neural technology company that provides professional solutions for both neuroscience and clinical neurology community worldwide.
PGDX is committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide.
PapGene is commercializing advanced molecular tests for the early detection of cancers by applying innovative NGS to routinely collected cytology samples.
CytoChip is commercializing a microfluidic technology that simplifies routine tests in clinics.
Cytek is commercializing a new disruptive type of flow cytometers.
Paragon Genomics develops rapid, easy-to-use, and ultra-high multiplex PCR-based target enrichment solutions for the Next-Generation Sequencing (NGS) markets.
GeneCast is an NGS based liquid biopsy service company for oncology.
Taproot is developing various implantable devices using a novel biocompatible material.
Next generation droplet-based digital PCR
3D-Med is a leading precision oncology company for both diagnostics and therapeutics.
Synbio Technologies is a biotechnology company which focuses on both next generation DNA technology and its applications.
Celero Systems is developing an ingestible technology platform for unobtrusive physiological monitoring, alerting and therapy delivery. Applications include medical, consumer, athletic and military.
Howsome biotech is the leading company in china focused on the field of automation of microbiological testing.
Bioelectronica is a research-stage biotechnology company building intelligent, digital tools for drug discovery, diagnostics and cell sorting.
Geneus is developing a new nanopore sequencing technology.
Taimei is the largest domestic Life Science cloud service provider.
Fangcun is a professional chronic disease management platform.
Jingyilin is a premier healthcare service company.
Yaputuo is the largest OBGYN education platform. It also manages Woyi OBGYN group.
FanYu is an online pregnancy and neonatal service platform.
Neighbor Doc is one of the pioneers in the primary healthcare market in China, which focus on the operation and manegement of chain clinics.
Unicorn is a boutique consulting firm for medical industries.
Ahu Edu is an online and offline medical education platform.
Yiheyunchuang is an online pathology service company.
Kidney Health is an innovative chronic kidney disease management company dedicated to the use of the internet, artificial intelligence and innovative medical technology to serve hundreds of millions of patients with chronic kidney disease in China.